世界最新医学信息文摘（连续型电子期刊）
世界最新醫學信息文摘（連續型電子期刊）
세계최신의학신식문적（련속형전자기간）
World Latest Medicine Information
2015年
63期
67-67,78
,共2页
韩勇%杨尚英%何春莲%杨禄辉
韓勇%楊尚英%何春蓮%楊祿輝
한용%양상영%하춘련%양록휘
阵发性室上性心动过速%普罗帕酮%维拉帕米
陣髮性室上性心動過速%普囉帕酮%維拉帕米
진발성실상성심동과속%보라파동%유랍파미
PsVt%Propafenone%Verapamil
目的：对比普罗帕酮和维拉帕米对阵发性室上性心动过速（PsVt)的治疗效果及各自的副反应。方法对我院急诊及入院的53例阵发性室上性心动过速随机分成普罗帕酮和维拉帕米治疗组，普罗帕酮组给予普罗帕酮70mg~140mg静注，维拉帕米组给予维拉帕米5mg~10mg静注。结果普罗帕酮和维拉帕米对阵发性室上性心动过速的治疗效果差异无统计学意义(P>0.05)，副作用维拉帕米较普罗帕酮高。结论 PsVt应首选普罗帕酮，维拉帕米可作为一线药物，但须注意其副作用。
目的：對比普囉帕酮和維拉帕米對陣髮性室上性心動過速（PsVt)的治療效果及各自的副反應。方法對我院急診及入院的53例陣髮性室上性心動過速隨機分成普囉帕酮和維拉帕米治療組，普囉帕酮組給予普囉帕酮70mg~140mg靜註，維拉帕米組給予維拉帕米5mg~10mg靜註。結果普囉帕酮和維拉帕米對陣髮性室上性心動過速的治療效果差異無統計學意義(P>0.05)，副作用維拉帕米較普囉帕酮高。結論 PsVt應首選普囉帕酮，維拉帕米可作為一線藥物，但鬚註意其副作用。
목적：대비보라파동화유랍파미대진발성실상성심동과속（PsVt)적치료효과급각자적부반응。방법대아원급진급입원적53례진발성실상성심동과속수궤분성보라파동화유랍파미치료조，보라파동조급여보라파동70mg~140mg정주，유랍파미조급여유랍파미5mg~10mg정주。결과보라파동화유랍파미대진발성실상성심동과속적치료효과차이무통계학의의(P>0.05)，부작용유랍파미교보라파동고。결론 PsVt응수선보라파동，유랍파미가작위일선약물，단수주의기부작용。
Objective: comparison of propafenone and verapamil against hair tachyarrhythmias supraventricular tachycardia (PsVt) treatment and their side effects. Methods:in emergency department of our hospital admission and 53 cases of paroxysmal supraventricular tachycardia speed were randomly divided into propafenone and verapamil treatment group and propafenone group given propafenone 70 mg ~ 140mg injection and verapamil group given verapamil 5mg ~ 10mg intravenous injection. Results:Propafenone and verapamil against hair supraventricular tachycardia speed difference of therapeutic effect was not statistically signiifcant (P>0.05), the side effects of verapamil was higher than that of the s&p roper ketone. Conclusion:PsV t should be the ifrst choice for the treatment of, but it should be noted for its side effects.
